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a b s t r a c t
Introduction: patients with sporadic colorectal cancer or cases associated with syndromes 
are at risk of having synchronous or metachronous cancer. Although it is an important 
subject, Brazilian data on the subject are scarce. 
Objective: to evaluate the incidence and epidemiological features in patients with synchro-
nous and metachronous colorectal cancer in a reference service of proctology in the Rio 
Grande do Sul. Methods: cross-sectional observational study, performed between January 
and July 2012, analyzing all patients admitted in the service that met the inclusion criteria. 
A retrospective review of records was performed, noting demographic variables, comorbidi-
ties and tumor-related variables. 
Results: 150 records were analyzed, of which 53.3% were males and mean age was 63 (± 
13.01) years old. The most frequently found tumor location was the sigmoid colon and 
high rectum (50.67%), followed by the lower rectum (36%). Adenocarcinomas were the most 
prevalent histological subtype (88%), followed by epidermoid tumors (1.33%). Hereditary 
syndromes were identified in five patients (3.33%), with four being Familial adenomatous 
polyposis (FAP) and one hereditary nonpolyposis colorectal cancer (HNPCC). Among the an-
alyzed patients, four (2.67%) had synchronous and one (0.67%) had metachronous cancer. 
Conclusion: the incidence of synchronous and metachronous colorectal cancer was, respec-
tively, 2.67% and 0.67%, results that corroborate those reported in international literature.
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Incidência e perfil epidemiológico do câncer colorretal sincrônico e 
metacrônico 
Palavras-chave:
Neoplasias de cólon
Neoplasias colorretais
Cirurgia colorretal
Epidemiologia
Cirurgia 
r e s u m o
Introdução: pacientes com diagnóstico de câncer colorretal esporádico ou associado a sín-
dromes correm risco de apresentar lesões sincrônicas ou metacrônicas. Embora seja rele-
vante, há escassez de informações sobre o tema na literatura nacional. 
Objetivo: avaliar a incidência e o perfil epidemiológico dos pacientes com tumor colorretal 
sincrônico e metacrônico em um serviço de referência em proctologia do Rio Grande do Sul. 
Método: estudo observacional transversal, realizado entre janeiro e julho de 2012, avaliando-se 
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pacientes atendidos no serviço que preencheram os critérios de inclusão. Revisaram-se os 
prontuários, registrando-se variáveis demográficas, comorbidades e variáveis relacionadas 
ao tumor. 
Resultados: analisaram-se 150 prontuários, sendo 53,3% do sexo masculino com média de 
idade de 63 (+13,01) anos. A topografia mais incidente foi cólon sigmoide e reto alto (50,67%) 
seguido do reto baixo (36%). O adenocarcinoma foi o subtipo histológico mais prevalente 
(88%) seguido pelo epidermoide (1,33%). Síndromes hereditárias foram identificadas em 
cinco pacientes (3,33%), sendo quatro com polipose adenomatosa familiar e um paciente 
com câncer colorretal hereditário não polipose. Dos 150 pacientes, quatro (2,67%) apresen-
taram neoplasia sincrônica e um (0,67%) lesão metacrônica. Conclusão: a incidência de tu-
mor colorretal sincrônico e metacrônico na população avaliada foi, respectivamente, 2,67% 
e 0,67%, resultados que corroboram achados da literatura estrangeira.
Introduction
The presence of more than one malignant colorectal lesion 
is classified according to its onset period as synchronous or 
metachronous lesions. Synchronous cancer is defined as two 
or more neoplasms identified simultaneously in the same 
patient or a second tumor identified up to six months after 
the initial diagnosis. In turn, metachronous tumor is defined 
as a second primary lesion identified six months after the 
detection of the first cancer and located no more than 3 cm 
from the anastomosis.
Temporally, metachronous tumors are classified as early 
if occurring within the first three years after the primary 
lesion, while those occurring after three years are consid-
ered late.1-3
It is speculated that synchronous colon carcinomas arise 
from a combination of environmental and genetic factors, 
as well as associated predisposing diseases. Among them is 
ulcerative colitis, a disease that, together with familial ade-
nomatous polyposis (FAP), corresponds to 10% of synchronic 
tumors3. In addition to FAP, another syndrome associated 
with multiple colorectal adenocarcinoma is Hereditary Non-
polyposis Colorectal Carcinoma (HNPCC), also known as 
Lynch syndrome, which corresponds to 1 to 3% of all colorec-
tal neoplasms.1,3
Estimates of the incidence of synchronous colorectal 
carcinomas vary, according to the literature, from 2 to 9%.2-8 
However, studies of greater internal validity, due to improved 
scientific design, state that the true prevalence is about 
4%2,3,6. The incidence of synchronous neoplasia is slightly 
lower if patients with HNPCC are excluded, decreasing the 
values  from 4 to 2.5%.9 In turn, few studies have evaluated 
the incidence of metachronous cancer, which is around 1%.2
This study aims to determine the prevalence of synchro-
nous and metachronous colorectal tumor in a reference Ser-
vice of Proctology in the state of Rio Grande do Sul, Brazil. 
Method
The present is a cross-sectional study carried out between 
January and July 2012, involving all patients treated at the 
Proctology Service of Hospital Geral de Caxias do Sul in the 
period between January 2010 and March 2012.
Inclusion criteria consisted of patients who underwent 
surgical resection, preoperative histopathological diagnosis, 
and postoperative anatomopathological tumor analysis and 
adequately prepared colonoscopy before surgery.
Variables such as age, gender, comorbidities, tumor loca-
tion, presence of synchronous or metachronous tumor, pres-
ence of hereditary syndrome and histological subtype were 
assessed using a data collection instrument obtained by pa-
tients’ charts review.
Assessed comorbidities were systemic arterial hyperten-
sion (SAH), diabetes mellitus (DM), obesity classified accord-
ing to body mass index (BMI), dyslipidemia, smoking, alco-
holism, lung disease, liver disease, kidney disease, thyroid 
disease and depression. Tumor location was defined as ce-
cum and ileocecal valve, right colon, hepatic flexure, trans-
verse colon, splenic flexure, left colon, sigmoid colon and high 
and low rectum. The presence of hereditary syndrome was 
evaluated and the syndromes included were FAP and HNPCC. 
Histologically, the tumors were classified as adenocarcinoma, 
epidermoid tumor, undifferentiated and polypoid lipoma.
Data were stored in Microsoft Excel 2007 spreadsheets and 
statistical analyses were performed using SPSS software, re-
lease 17.0®.
Results
From January to July 2012, medical records of all patients with 
colorectal cancer treated at the Proctology Service from Janu-
ary 2010 to March 2012 were retrospectively reviewed. A total 
of 150 records were analyzed, of which 53.3% were males with 
a mean age of 63 (± 13.01) years old. Among the comorbidities 
assessed, the most prevalent was hypertension, seen in 24.6% 
of patients, followed by diabetes mellitus, lung and heart dis-
ease (Table 1). 
Regarding tumor location, the most affected portion was 
the sigmoid colon and high rectum (50.67%) followed by the 
low rectum (36%). Adenocarcinoma was the most prevalent 
histological subtype, corresponding to 89.3% of cases, fol-
lowed by epidermoid tumors (1.33%) and undifferentiated and 
polypoid lipomas, both with an incidence of 0.67% (Table 2). 
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Hereditary syndromes were identified in five patients 
(3.33%), all with adenocarcinoma histology. Of these, four pa-
tients had FAP and 1 had HNPCC.
From 150 patients, only four (2.67%) had synchronous 
neoplasia. The incidence of metachronous tumor was 0,67% 
(one patient), whose tumor location was in the cecum 
(Table 3). The mean age of patients with synchronous tumors 
was 61.5 (± 13.02) years old, of which three were females. The 
adenocarcinoma histological subtype was seen in four pa-
tients and only one patient was diagnosed with a hereditary 
syndrome (FAP).
When analyzing tumor characteristics of the four patients 
with synchronous lesions, it was demonstrated that two pa-
tients were classified as C according to Dukes’ criteria; the 
tumors did not have a predominant topography and total col-
ectomy was indicated in three patients, with proctocolectomy 
being indicated for the fourth case (Table 4). 
Discussion
Colon cancer is the third most common malignancy in Bra-
zil10 and the second most common cause of death from ma-
lignancy in the western world. The risk of developing a tumor 
throughout the lifetime in the general population is approxi-
mately  5%. United States data estimated that 141,210 new 
colorectal cancer cases were diagnosed in the US in 2011.11
Patients with sporadic colorectal cancer or cases associat-
ed with genetic syndromes are at risk of developing synchro-
nous tumors at diagnosis, as well as metachronous lesions 
in the follow-up.6 Due to the possibility of the existence of 
synchronous tumors, all patients with a diagnosis of this type 
of tumor should have their colon thoroughly analyzed preop-
eratively to investigate the presence of a second or third le-
sion, which can modify the extent of the surgical procedure.12 
Although colonoscopy is the test of choice in the preop-
erative investigation, it is not, even when associated with 
double-contrast barium enema, enough to detect all syn-
chronous lesions, with a sensitivity of 66%.13 Therefore, the 
palpation of the entire colon and rectum is recommended 
during surgery to detect synchronous tumors not identified 
at the preoperative evaluation.2,13 
The preoperative detection of synchronous tumors not 
only allows establishing the appropriate surgical strategy, 
but also facilitates the follow-up plan after surgery. It is 
believed that the presence of synchronous lesions require 
a modification in surgical extension in 34.4% of patients, 
as they indicate lesions in surgically distinct colonic seg-
ments.2,6 
Estimates of the incidence of synchronous colorectal ade-
nocarcinoma vary, according to the literature, from 2 to 9%.2-
8 The results of the present study are consistent with the 
literature, as the incidence in this population was 2.8%. We 
believe that the incidence found was lower than that report-
ed in other studies due to the smaller number of patients. 
However, if we evaluate that only 4.5% of our sample had a 
Table 3 – Incidence of synchronous and metachronous 
tumors.
Absolute value Percentage value (%)
Synchronous tumor  4 2.67
Metachronous 
tumor 
 1 0.67
Single tumor  145 96.67
Total  150 100
Table 2 – Tumor-related characteristics.
Absolute value Percentage value (%)
Tumor location 
Sigmoid colon 
and high 
rectum
Low rectum 
Cecum and 
ileocecal valve 
Transverse colon 
Splenic flexure 
Hepatic angle 
Left colon 
Right colon 
Not specified
Total
 76
 54
 3
 2
 2
 1
 1
 1
 10
 150
50.67
36
2
1.33
1.33
0.67
0.67
0.67
6.67
100
Histological 
subtype 
Adenocarcinoma
Epidermoid
Undifferentiated
Polypoid lipoma 
Not specified
Total
 134
 2
 1
 1
 12
 150
89.3
1.33
0.67
0.67
8
100
Hereditary 
syndrome 
FAP
HNPCC
No syndrome
Total
 4
 1
 145
 150
2.67
0.67
96.67
100
FAP, familial adenomatous polyposis; HNPCC, nonpolyposis 
colorectal cancer.
Table 1 – General sample characteristics.
Absolute value Percentage value (%)
Gender
Male
Female
Total
 80
 70
 150
53.3
46.7
100
Comorbidities
SAH
DM
Pneumopathy
Cardiopathy
Smoking
Obesity
Hepatopathy
Thyroidopathy
Breast cancer 
Mood disorder 
Parkinson’s 
disease 
No comorbidities
Total
 37
 9
 6
 4
 3
 2
 2
 2
 1
 1
 1
 82
 150
24.6
 6
 4
2.67
 2
1.33
1.33
1.33
0.67
0.67
0.67
54.67
100
SAH, systemic arterial hypertension; DM, diabetes mellitus.
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diagnosis of hereditary adenocarcinoma and only one of these 
cases had synchronous tumors, we observe that the results of 
the present study are very similar to those described by other 
authors. According to Fante et al., the incidence of synchronous 
neoplasia is slightly lower if patients with hereditary patholo-
gies are excluded, decreasing  from 4 to 2.5%.9  
Of the four cases of synchronous tumors, two affected the 
rectal segment, whereas the remaining lesions were distribut-
ed between the cecum and sigmoid colon. This finding corrobo-
rates previous descriptions that suggest a higher prevalence of 
synchronous adenocarcinoma in cancers arising in the colon, 
when compared to rectal tumors.6 
Risk factors for synchronous tumors include male sex, fam-
ily history, advanced age and the presence of synchronous ad-
enomas. In our sample, 75% were females. However, this find-
ing has no statistical significance due to the small number of 
patients evaluated.
Age is a controversial subject, as several studies have indi-
cated that synchronous tumors occur in older patients,13 while 
other studies have shown that the patients were younger. More-
over, there are studies that showed no significant difference 
regarding age of patients with a solitary tumor in comparison 
to those with synchronous tumors.2,3 The divergence regarding 
the results is possibly due to the fact that synchronous tumors 
were not stratified by location or genetic predisposition. 
This fact is demonstrated by the study of Fukatsu et al., in 
which there was no difference in age between the groups with 
isolated and synchronous tumors; however, when these were 
analyzed for tumor location, it was shown that the presence of 
both lesions in the right colon occurs in older patients, whereas 
both lesions in the left colon occur in younger patients4. This 
finding supports the theory that tumors of the right colon and 
left colon have distinct molecular biology features and differ-
ent risk factors, as right colon tumors are more prevalent in the 
elderly and in females, while tumors of the left colon are more 
prevalent in younger males.
Moreover, few studies have evaluated the incidence of meta-
chronous tumors. According to Chen et al., the incidence is ap-
proximately 1% (2), similar to that found in this study, of which 
incidence was 0.67%.
Conclusion
The incidence of synchronous colorectal tumors in this popu-
lation was 2.67%, which is consistent with values  previously 
reported in the literature, especially when cases of hereditary 
tumors were excluded. Moreover, the incidence of metachro-
nous tumor was 0.67%, which also corroborates the literature 
findings, although few authors have addressed this issue in 
particular.
Table 4 – Characteristics of patients with synchronous colorectal cancer. 
Patient TNM Dukes classification Topography 1 Topography 2 Surgery
Case 1 pT4N2M0 C Transversal Low rectum Total colectomy 
Case 2 pT1N0M0 A Splenic flexure Cecum and Ileocecal valve Total colectomy
Case 3 pT1N0M0 A Transversal Right colon Total colectomy
Case 4 pT3n1m0 C Low rectum Left colon Proctocolectomy
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